Delivery Order SPE2DB22D3009-SPE2DB23FAU17
Award Date 8/1/23
Potential Completion Date 8/2/23
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $5,153.50 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561454927 capsules of CAPLYTA, a 21mg antipsychotic medication, for delivery to a facility located in Conshohocken, Pennsylvania. The single delivery is to be completed by July 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for CAPLYTA capsules...
- The Defense Logistics Agency awarded a $11.89K delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). This is a firm fixed price, non-set-aside contract with a completion date of July 24, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. CAPLYTA is an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a $4,378.69 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Caplyta 42 mg capsules (30-count units), with completion targeted for November 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Caplyta is an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of CAPLYTA 21 mg capsules (30-count units) valued at $3,467.29. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure with an ultimate completion date of October 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. CAPLYTA is a prescription antipsychotic medication used in the...
- The Defense Logistics Agency awarded a delivery order valued at $3,210.29 to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units) on July 18, 2025, with completion anticipated by July 21, 2025. This firm fixed price delivery order carries no set-aside designation and represents a competitive award to the prime contractor based in Conshohocken, Pennsylvania. CAPLYTA is an atypical antipsychotic medication used in the treatment of schizophrenia and bipolar disorder, reflecting...
- The Defense Logistics Agency awarded a $14,646.30 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with a completion deadline of June 3, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. CAPLYTA is a prescription antipsychotic medication used in the treatment of schizophrenia and bipolar depression, representing the type of...
- The Defense Logistics Agency awarded a delivery order valued at $2,384.16 to AmerisourceBergen Drug Corp for CAPLYTA (lumateperone) 21 mg capsules (quantity: 30) on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. CAPLYTA is an atypical antipsychotic medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 21 mg capsules (30-count units) under a firm fixed-price contract valued at $16,991.12. This non-competitive delivery order was issued on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CAPLYTA is an atypical antipsychotic medication used in the treatment...
- The Defense Logistics Agency awarded a delivery order valued at $4,966.50 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units). This competitively awarded, firm fixed price delivery order was issued on November 7, 2025, with an ultimate completion date of November 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CAPLYTA is an atypical antipsychotic medication used in the treatment of...
- <p>The Defense Logistics Agency awarded a $7,356 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of CAPLYTA, a 10.5 mg antipsychotic medication. As the prime contractor, Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by August 18, 2023. No subcontractors or set aside designations were indicated. This order was placed under an existing DLA contract vehicle to support the agency's medical supply needs.</p>